Supportive Care For Hematological Malignancies

Size: px
Start display at page:

Download "Supportive Care For Hematological Malignancies"

Transcription

1 Supportive Care For Hematological Malignancies Nawaf Alkhayat, MD Pediatric Hematology, Oncology & BMT Prince Sultan Military Medical City Riyadh, KSA

2 Supportive care Definition Why we need supportive care? Cost of supportive care Guidelines and adherence Best location Designing of treatment units & Easy access Satellite services, home care Religious factors Government financial aids Age groups Long term follow up programs Palliative care & hospice care Educational programs Research gap 2

3 Not 1 man show! 3

4 WHO, When, What 4

5 Definition the provision of the necessary services for those living with or affected by cancer to meet their informational, emotional, spiritual, social or physical need during their diagnostic treatment or follow-up phases encompassing issues of health promotion and prevention, survivorship, palliation and bereavement What is supportive care? Can Oncol Nurs J. 1994;4:

6 Definition...In other words, supportive care is anything one does for the patient that is not aimed directly at curing his disease but rather is focused at helping the patient and family get through the illness in the best possible condition. Clearly this type of help would need to be broad in scope and as varied as the individuals requiring it What is supportive care? Can Oncol Nurs J. 1994;4:

7 Supportive care is for 7

8 Medical Supportive Care Disease & treatment Febrile Neutropenia Tumor Lysis Syndrome Organ dysfunction Emergencies The Acute Abdomen Thrombotic Disorders Pain Management Nausea and Vomiting Oral Mouth Care and Mucositis Nutrition Radiation Side Effects Prevention of Infection Hematopoietic Growth Factors Central Venous Catheters Care Transfusion Support 8

9 Why we need supportive care? How can we convince the decision maker about it? 9 story

10 10 Pediatr Blood Cancer 2012;59: , Improved Outcome in Pediatric AML Due To Augmented Supportive Care. Wasil Jastaniah, et al

11 Era1 From 1996 to 2002 (era1), supportive care strategies included Hickman catheters, blood products, antibiotics, antiemetics, mouth and skin care, and antifungal prophylaxis Era2 environmental measures including expert personnel and high-efficiency particulate air (HEPA) filtration. A Pediatric Oncology Walk-In Emergency Room (POWER) set up to provide 24-hour, 7 day a week emergency management. Unified febrile neutropenia protocol antimicrobial cultures and sensitivity patterns were reviewed every 2 years to optimize antimicrobial choice 11 Pediatr Blood Cancer 2012;59: , Improved Outcome in Pediatric AML Due To Augmented Supportive Care. Wasil Jastaniah, et al

12 12 Pediatr Blood Cancer 2012;59: , Improved Outcome in Pediatric AML Due To Augmented Supportive Care. Wasil Jastaniah, et al

13 Cost of supportive care Expenditures on cancer treatment, total and by type of service, 2001 (adjusted to 2011) & 2011 Source: US Center for Financing, Access, and Cost Trends, AHRQ, Household Component of the 13 Medical Expenditure Panel Survey, 2001 and 2011

14 Cost of supportive care Mean expenditures on cancer treatment per person with expense, by type of service, 2001 (adjusted to 2011) and 2011 Source: US Center for Financing, Access, and Cost Trends, AHRQ, Household Component of the 14 Medical Expenditure Panel Survey, 2001 and 2011

15 Guidelines and adherence, FN Research gap Compliance Outcomes 41.5% Fully Compliant (6) 6.2% ICU transfer 40.0% Partially Compliant (4-5) 4.6% inpatient mortality 18.5% Non-compliant (0-3) 4.6% adverse antibiotic reaction 9.2% Clostridium difficile, 90 days 7.7% new VRE, 90 days (60% infection; 40% colonization) Retrospective Analysis of Compliance in Guideline-Based Management of Neutropenic Fever. M J Hoffman, et al 15

16 Guidelines and adherence, FN 16 Retrospective Analysis of Compliance in Guideline-Based Management of Neutropenic Fever. M J Hoffman, et al

17 Guidelines and adherence, FN Despite FN guidelines, compliance is poor mainly driven by vancomycin overuse In light of the relatively high rate of adverse drug reactions, new Clostridium difficile and VRE cases, further intervention is needed to improve compliance with established NF guidelines Retrospective Analysis of Compliance in Guideline-Based Management of Neutropenic Fever. M J Hoffman, et al 17

18 Guidelines and adherence, CINV Reported barriers/reasons interfering with using guideline-recommended antiemetics Highly HEC, Moderately MEC: emetogenic chemotherapy CINV and adherence to antiemetic guidelines, Rebecca Clark-Snow, Supportive Care in Cancer, February 2018, Volume 26, Issue 2, pp

19 Where it can be delivered? 19

20 Best location Research gap ER vs OPD vs Daycase vs In-patient 20

21 Design Design of treatment units should address the need of the special population Dedicated center vs hospital department Research gap 21

22 Dedicated center vs hospital dept. 22

23 Easy access where Satellite services home care Research gap 23

24 Clinic nurse vs Electronic Booking an appointment Report symptoms Report death Full HIS 24

25 financial aids The Financial Toxicity of Cancer Treatment, Zafara, et al, THE ONCOLOGIST February 26, 2013

26 We can

27 Religious factors Research gap Cancer 2015;121: R/S was associated with improved overall physical health (z , P <.001); this relation was not moderated by socio-demographic or clinical variables. associated with physical well-being (z , P <.001), functional well-being (z , P <.001), and Physical symptoms (z , P <.001) greater religion/spirituality is associated with better patient-reported physical health 27

28 Religious factors Research gap Cancer 2015;121: Overall R/S was associated with overall physical health (z , P <.001); this relation was not moderated by sociodemographic or clinical variables. associated with physical well-being (z , P <.001), functional well-being (z , P <.001), and Physical symptoms (z , P <.001) greater religion/spirituality is associated with better patient-reported physical health 28

29 Age groups Pediatric, adults, geriatrics 29

30 Educational programs Research gap Vs WhatsApp 30

31 Long term follow up programs Research gap Cancer survivorship App: PROM (patient reported outcome measures) Organs dysfunction Fertility Depression - adolescent and young adult (AYA) 31

32 Palliative care & hospice care Research gap 32

33 What, when, who Research gap 33

34 34

Developing Supportive Care in Serbia

Developing Supportive Care in Serbia Developing Supportive Care in Serbia Prof Snežana Bošnjak Institute for Oncology and Radiology of Serbia National Cancer Center Dept. Supportive Oncology & Palliative Care ESO & ESMO Faculty member Faculty

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

Hematologic Malignancies 2013 Retrospective Study at Truman Medical Center

Hematologic Malignancies 2013 Retrospective Study at Truman Medical Center Hematologic Malignancies 2013 Retrospective Study at Truman Medical Center Kristen Strasser, MD & Abdulraheem Qasem, MD Introduction: Hematologic Malignancies includes malignant diseases of the bone marrow

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

Past Chapter Summaries Educational Topics Summary

Past Chapter Summaries Educational Topics Summary Below is a comprehensive summary of all of the different Educational Topics our Local Chapters have presented and/or provided 2014 1. The most powerful force in nursing 2. Hope and meaning in life in adolescent

More information

HIGHLIGHTS ESMO 2017 SUPPORTIVE AND PALLIATIVE CARE

HIGHLIGHTS ESMO 2017 SUPPORTIVE AND PALLIATIVE CARE HIGHLIGHTS ESMO 2017 SUPPORTIVE AND PALLIATIVE CARE Florian Scotté MD-PhD Hôpital Foch, Suresnes, France esmo.org DISCLOSURE SLIDE Consultant / Advisory Boards / Speaker: Tesaro, Sanofi, Roche, MSD, TEVA,

More information

Student Project PRACTICE-BASED RESEARCH

Student Project PRACTICE-BASED RESEARCH Pharmacist-Driven Management of Chemotherapy Induced Nausea and Vomiting in Hospitalized Adult Oncology Patients. A Retrospective Comparative Study Ramy Elshaboury, PharmD 1 and Kathleen Green, PharmD,

More information

Patient Experience Research in Malignant Hematology: describing the lived experience of illness with acute myeloid leukemia

Patient Experience Research in Malignant Hematology: describing the lived experience of illness with acute myeloid leukemia Patient Experience Research in Malignant Hematology: describing the lived experience of illness with acute myeloid leukemia Thomas W. LeBlanc, MD, MA, MHS, FAAHPM Associate Professor of Medicine Division

More information

Systemic management of pancreatic cancer: Supportive care

Systemic management of pancreatic cancer: Supportive care Systemic management of pancreatic cancer: Supportive care Snežana Bošnjak Institute for Oncology and Radiology of Serbia Dept. Supportive Oncology & Palliative Care Serbia, Belgrade Integrative Oncology

More information

Oncology Nursing Society Registry in Collaboration with CE City 2015 Performance Measure Specifications

Oncology Nursing Society Registry in Collaboration with CE City 2015 Performance Measure Specifications 1 ONSQIR 1 Non-PRQS Measure Oncology Nursing Society Registry in Collaboration with CE City 2015 Performance Measure Specifications Performance Measure Name: Symptom Assessment 1-o1a Symptom Assessment

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Abdomen, acute, in oncological surgery patients, critical care issues in, 101 102 Acquired factor VIII inhibitors, in critically ill cancer

More information

eviq.org.au A/Prof Jeremy Shapiro Cabrini Hematology and Oncology Centre Chair EVIQ Medical Oncology Committee PCPA 2017 Jeremy Shapiro

eviq.org.au A/Prof Jeremy Shapiro Cabrini Hematology and Oncology Centre Chair EVIQ Medical Oncology Committee PCPA 2017 Jeremy Shapiro eviq.org.au A/Prof Jeremy Shapiro Cabrini Hematology and Oncology Centre Chair EVIQ Medical Oncology Committee What is eviq? Provides evidence-based best practice cancer treatment information Point of

More information

AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF)

AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF) AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF) Colony Stimulating Factor (CSF) Neupogen (filgrastim; G-CSF), Neulasta (peg-filgrastim; G-CSF); Neulasa

More information

AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF)

AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF) AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF) Colony Stimulating Factor (CSF) Neupogen (filgrastim; G-CSF), Neulasta (peg-filgrastim; G-CSF); Neulasa

More information

Cancer and Advance Care Planning You ve been diagnosed with cancer. Now what?

Cancer and Advance Care Planning You ve been diagnosed with cancer. Now what? Cancer and Advance Care Planning You ve been diagnosed with cancer. Now what? ACP Cancer Booklet-- Patient_FINAL.indd 1 You have a lot to think about and it can be difficult to know where to start. One

More information

2 Diagnosis and Staging of Cancer 2.1 Pathophysiology of cancer 2.2 Classification and staging 2.3 Diagnostic measures for specific cancer types

2 Diagnosis and Staging of Cancer 2.1 Pathophysiology of cancer 2.2 Classification and staging 2.3 Diagnostic measures for specific cancer types Oncology Nursing Sub-Specialty Module Reference: Gobel B. M., Triest-Robertson S. & Vogel W.H. (Eds). (205). Advanced Oncology Nursing Certificate Review and Resources Manual. Pittsburgh: Oncology Nursing

More information

Welcome to Oncology as a Nurse Practitioner!

Welcome to Oncology as a Nurse Practitioner! Welcome to Oncology as a Nurse Practitioner! As a nurse practitioner in cancer care there are many resources that can help orient you to the care of the patient and family with cancer. The members of the

More information

Supportive Care makes excellent cancer care possible

Supportive Care makes excellent cancer care possible Supportive Care makes excellent cancer care possible Irma Verdonck-de Leeuw With many thanks to Age Schultz and Dorothy M Keefe Supportive Care in Cancer The prevention & management of the adverse effects

More information

2018 OCN Keywords January 22, 2018 Subject Area Weight Keywords

2018 OCN Keywords January 22, 2018 Subject Area Weight Keywords Subject Area Weight Keywords Care Continuum 19% Care Continuum Coordination of Care Navigation Psychosocial Symptom Management Health Promotion/Screening and Early Detection Disease Prevention High-Risk

More information

International Symposium on Supportive Care in Cancer, MASCC/ISOO 2013, Berlin, Germany. What was hot at MASCC/ISOO Annual Meeting this year?

International Symposium on Supportive Care in Cancer, MASCC/ISOO 2013, Berlin, Germany. What was hot at MASCC/ISOO Annual Meeting this year? International Symposium on Supportive Care in Cancer, MASCC/ISOO 2013, Berlin, Germany What was hot at MASCC/ISOO Annual Meeting this year? Supportive Care Makes Excellent Cancer Care Possible. This slogan

More information

A systemic review and meta analysis of Aprepitant Combination Regimens (ACR) for prevention of Chemotherapy induced Nausea

A systemic review and meta analysis of Aprepitant Combination Regimens (ACR) for prevention of Chemotherapy induced Nausea A systemic review and meta analysis of Aprepitant Combination Regimens (ACR) for prevention of Chemotherapy induced Nausea and Vomiting (CINV) in adults Fahad Zubair, PGY 3 UB CHS Internal Medicine Nausea

More information

Stem cell transplantation. Dr Mohammed Karodia NHLS & UP

Stem cell transplantation. Dr Mohammed Karodia NHLS & UP Stem cell transplantation Dr Mohammed Karodia NHLS & UP The use of haemopoeitic stem cells from a donor harvested from peripheral blood or bone marrow, to repopulate recipient bone marrow. Allogeneic From

More information

9/19/2017. Population-Based Palliative Care: The Next Phase of Clinical Care, Education, and Research. Population-Based Palliative Care JR:

9/19/2017. Population-Based Palliative Care: The Next Phase of Clinical Care, Education, and Research. Population-Based Palliative Care JR: Population-Based Palliative Care: The Next Phase of Clinical Care, Education, and Research David Casarett, MD, MA Chief of Palliative Care Professor of Medicine Duke University/Duke Health Population-Based

More information

South West Regional Cancer Program. Cancer Plan

South West Regional Cancer Program. Cancer Plan South West Regional Cancer Program Cancer Plan 2016-2019 1. Cancer System Planning Cancer Care Ontario s role as the government s cancer advisor includes the development and implementation of a provincial

More information

Ready to answer the questions?

Ready to answer the questions? 파워포인트문서의제목 Reference 1. IDSA GUIDELINES. Clinical Practice Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Disease Society of America.

More information

5/2/2016. Caring for Adolescents and Young Adults with Cancer. Objectives. AYA Oncology. Cancer Incidence: SEER 18, , ages

5/2/2016. Caring for Adolescents and Young Adults with Cancer. Objectives. AYA Oncology. Cancer Incidence: SEER 18, , ages Objectives Caring for Adolescents and Young Adults with Cancer Oncology Nursing: Planting Seeds of Hope and Healing May 4 th, 2016 Describe distinctive aspects of disease biology in AYA population List

More information

Managing Older Patients With Lymphoma and Multiple Myeloma

Managing Older Patients With Lymphoma and Multiple Myeloma 2006 ONS Congress Webcast Evaluation Form Managing Older Patients With Lymphoma and Multiple Myeloma Session length: 1 hour, 45 minutes Contact hours: 1.5 Pharmacology hours offered: 15 minutes How to

More information

The New Role of Cancer Patient Engagement in Value Based Models

The New Role of Cancer Patient Engagement in Value Based Models Mini Summit XIX: Case Studies in Specialty Medical Homes: How to Design APMs to Support Patients with Serious Health Conditions that Cannot be Managed by a PCP Ray Page, DO PhD The New Role of Cancer Patient

More information

Advanced Pediatric Emergency Medicine Assembly

Advanced Pediatric Emergency Medicine Assembly (+)Joan Shook, MD, FACEP Professor of Pediatrics, Baylor College of Medicine; Chief Safety Officer and Chief Clinical Information Officer, Texas Children's Hospital Advanced Pediatric Emergency Medicine

More information

PART one. The Palliative Care Spectrum: Providing Care Across Settings

PART one. The Palliative Care Spectrum: Providing Care Across Settings PART one The Palliative Care Spectrum: Providing Care Across Settings Chapter 1 An Introduction to Palliative Pharmacy Care Jennifer M. Strickland To palliate means to alleviate. Palliative care, as the

More information

Child cancer scenarios. GP CME Rotorua 2014

Child cancer scenarios. GP CME Rotorua 2014 Child cancer scenarios GP CME Rotorua 2014 Scenario 1 Chickenpox is in the school What is the response when the parent of a child on chemotherapy rings the practice? Scenario 2 -chickenpox Varicella is

More information

Role of Pharmacist in Supportive care cancer

Role of Pharmacist in Supportive care cancer Role of Pharmacist in Supportive care cancer Manit Sae-teaw B.Pharm, BCOP, BCP Grad. Dip. In Pharmacotherapy Faculty of Pharmaceutical Science Ubon Ratchathani University 1 Outline Cancer facts Supportive

More information

Hematology/Oncology Inpatient Rotation (Gold) PL2 Residents

Hematology/Oncology Inpatient Rotation (Gold) PL2 Residents PL2 Residents The Gold team at Comer Children s Hospital at the University of Chicago is comprised of 4 residents who care exclusively for inpatients suffering from hematologic and oncologic conditions.

More information

The aggressiveness of cancer care near the end of life: Is it a quality of care issue?

The aggressiveness of cancer care near the end of life: Is it a quality of care issue? The aggressiveness of cancer care near the end of life: Is it a quality of care issue? Craig Earle, MD MSc FRCPC Director, Health Services Research Program for Cancer Care Ontario & the Ontario Institute

More information

The aggressiveness of cancer care near the end of life: Is it a quality of care issue?

The aggressiveness of cancer care near the end of life: Is it a quality of care issue? The aggressiveness of cancer care near the end of life: Is it a quality of care issue? Craig Earle, MD MSc FRCPC Director, Health Services Research Program for Cancer Care Ontario & the Ontario Institute

More information

Systemic management of pancreatic cancer: Supportive care

Systemic management of pancreatic cancer: Supportive care Systemic management of pancreatic cancer: Supportive care Snežana Bošnjak @bosnjaksupport Institute for Oncology and Radiology of Serbia Serbia, Belgrade Supportive Care in Cancer The prevention & management

More information

Information contained in this listing is collected and maintained by the American Board of Internal Medicine.

Information contained in this listing is collected and maintained by the American Board of Internal Medicine. 1936-1940 1936 1937 1938 1939 1940 Decade Internal Medicine 27 209 90 227 255 808 1941-1950 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 Decade Internal Medicine 242 204 342 271 314 473 654 486 335

More information

patient decision aid advanced lung cancer

patient decision aid advanced lung cancer patient decision aid advanced lung cancer Introduction This aid is meant to supplement conversations with your care team. Patients who have used a decision aid like this said it helped them make care choices

More information

The role of palliative care in non-malignant disease

The role of palliative care in non-malignant disease The role of palliative care in non-malignant disease Dr. Tony O Brien Consultant Physician in Palliative Medicine Marymount Hospice & Cork University Hospital School of Medicine, University College, Cork

More information

ANTIEMETICS and FEBRILE NEUTROPENIA. Matti S. Aapro Genolier Switzerland

ANTIEMETICS and FEBRILE NEUTROPENIA. Matti S. Aapro Genolier Switzerland ANTIEMETICS and FEBRILE NEUTROPENIA Matti S. Aapro Genolier Switzerland 2010 Multinational Association of Supportive Care in Cancer TM All rights reserved worldwide. Disclosures Collaborations in this

More information

University of Michigan Health System Internal Medicine Residency. Hematology/Oncology Curriculum: University Hospital Hematology Consultation Service

University of Michigan Health System Internal Medicine Residency. Hematology/Oncology Curriculum: University Hospital Hematology Consultation Service University of Michigan Health System Internal Medicine Residency Hematology/Oncology Curriculum: University Hospital Hematology Consultation Service Version date: 12/16/2009 Subspecialty Education Coordinator:

More information

Applying MOHO with Adolescents & Adults with Cancer. Brent Braveman, PhD., OTR/L, FAOTA Donna Kelly, OTR/L, M.ED, CLT

Applying MOHO with Adolescents & Adults with Cancer. Brent Braveman, PhD., OTR/L, FAOTA Donna Kelly, OTR/L, M.ED, CLT Applying MOHO with Adolescents & Adults with Cancer Brent Braveman, PhD., OTR/L, FAOTA Donna Kelly, OTR/L, M.ED, CLT Applying MOHO with Adolescents & Adults with Cancer 2 Learning Objectives At the end

More information

Acute Oncology Martin Eatock Consultant Medical Oncologist NICaN Medical Director

Acute Oncology Martin Eatock Consultant Medical Oncologist NICaN Medical Director Acute Oncology 2014 Martin Eatock Consultant Medical Oncologist NICaN Medical Director Patients admitted with cancer have a longer than average stay Berger et al. Clin Medicine (2013) Questions If your

More information

2014 Medicare (and Private Insurance) Payment Reform for Oncology. Ensuring the Delivery of Quality & Value-Based Cancer Care

2014 Medicare (and Private Insurance) Payment Reform for Oncology. Ensuring the Delivery of Quality & Value-Based Cancer Care 2014 Medicare (and Private Insurance) Payment Reform for Oncology Ensuring the Delivery of Quality & Value-Based Cancer Care PHASE 1 PHASE 2 PHASE 3 PHASE 4 Quality Reporting Quality & Value Performance

More information

Guideline for the Management of Fever and Neutropenia in Children with Cancer and/or Undergoing Hematopoietic Stem-Cell Transplantation

Guideline for the Management of Fever and Neutropenia in Children with Cancer and/or Undergoing Hematopoietic Stem-Cell Transplantation Guideline for the Management of Fever Neutropenia in Children with Cancer /or Undergoing Hematopoietic Stem-Cell Transplantation COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive

More information

Cancer Survivorship in the U.S.A: Models of Follow-up Care

Cancer Survivorship in the U.S.A: Models of Follow-up Care National Cancer Institute U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Cancer Survivorship in the U.S.A: Models of Follow-up Care Julia H Rowland, PhD, Director Office of

More information

Regulatory Status FDA-approved indications: Emend is a substance P/neurokinin 1 (NK1) receptor antagonist, indicated: (1-2)

Regulatory Status FDA-approved indications: Emend is a substance P/neurokinin 1 (NK1) receptor antagonist, indicated: (1-2) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.05 Section: Prescription Drugs Effective Date: April 1, 2017 Subject: Emend Page: 1 of 6 Last Review

More information

Management of common chemotherapy related side effects. Dr Lee-Ann Jones

Management of common chemotherapy related side effects. Dr Lee-Ann Jones Management of common chemotherapy related side effects Dr Lee-Ann Jones Deciphering oncology terms treatment intent Chemotherapy terms / intents Adjuvant chemotherapy - Chemotherapy given to destroy residual/

More information

Quick Facts about Bile Duct Cancer

Quick Facts about Bile Duct Cancer Quick Facts about Bile Duct Cancer What is the bile duct? The bile duct is a thin tube, about 10 centimetres to 15 centimetres long, that carries a fluid called bile from the liver and gallbladder to the

More information

Neutropenic Fever 1 InpatientPediatric Treatment

Neutropenic Fever 1 InpatientPediatric Treatment Neutropenic Fever InpatientPediatric Treatment (Hematologic Cancers and Stem Cell Patients) te: This algorithm should not be used for patients receiving CAR cell therapy. Page of 8 Patient presents with

More information

Competent Pain Management for Older Patients With Cancer

Competent Pain Management for Older Patients With Cancer Session length: 2 hours, 53 minutes Contact hours: 3.5 Pharmacology hours offered: 30 minutes 2005 ONS Virtual Institutes of Learning Evaluation Form Competent Pain Management for Older Patients With Cancer

More information

The Role of Observation Care in the Evaluation and Management of Cancer Emergencies

The Role of Observation Care in the Evaluation and Management of Cancer Emergencies The Role of Observation Care in the Evaluation and Management of Cancer Emergencies Adam Klotz, MD Associate Attending Physician Memorial Sloan Kettering Cancer Center FACULTY DISCLOSURE Nothing to disclose

More information

PALLIATIVE CARE IN HEMATOLOGIC MALIGNANCIES KEDAR KIRTANE MD FRED HUTCHINSON CANCER RESEARCH CENTER UNIVERSITY OF WASHINGTON

PALLIATIVE CARE IN HEMATOLOGIC MALIGNANCIES KEDAR KIRTANE MD FRED HUTCHINSON CANCER RESEARCH CENTER UNIVERSITY OF WASHINGTON PALLIATIVE CARE IN HEMATOLOGIC MALIGNANCIES KEDAR KIRTANE MD FRED HUTCHINSON CANCER RESEARCH CENTER UNIVERSITY OF WASHINGTON DISCLOSURES OBJECTIVES To discuss how hematologic malignancies qualitatively

More information

July May 2013 MSc University of Michigan Rackham School of Graduate Studies Ann Arbor, Michigan Health and Health Care Research

July May 2013 MSc University of Michigan Rackham School of Graduate Studies Ann Arbor, Michigan Health and Health Care Research Emily L. Mueller, MD, MSc Pediatric Hematology-Oncology/Pediatric Health Services Research Riley Hospital for Children at Indiana University School of Medicine 410 West 10th Street, Suite 2000A Indianapolis,

More information

Neutropenic Sepsis Acute General Management and Support. Ernie Marshall Macmillan Consultant in Medical Oncology Clatterbridge Centre for Oncology

Neutropenic Sepsis Acute General Management and Support. Ernie Marshall Macmillan Consultant in Medical Oncology Clatterbridge Centre for Oncology Neutropenic Sepsis Acute General Management and Support Ernie Marshall Macmillan Consultant in Medical Oncology Clatterbridge Centre for Oncology Who Am I? I am A Medical Oncologist (MCCN) Site specialist

More information

Balancing Evidence and Clinical Practice in the Treatment of Localized Breast Cancer

Balancing Evidence and Clinical Practice in the Treatment of Localized Breast Cancer 2006 ONS Congress Webcast Evaluation Form Balancing Evidence and Clinical Practice in the Treatment of Localized Breast Cancer Session length: 1 hour, 49 minutes Contact hours: 1.6 Pharmacology hours offered:

More information

Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident

Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident Residents: Pediatric residents at the PL3 level Prerequisites: Successful completion or waiver

More information

Shannon Carty, PGY-2 ICCR IRB Project Proposal April 9, 2008

Shannon Carty, PGY-2 ICCR IRB Project Proposal April 9, 2008 Shannon Carty, PGY-2 ICCR IRB Project Proposal April 9, 2008 Study Title: Observational Study to Determine the Effect of an Emergency Department Adult Oncology Stat Antibiotic Protocol on Clinical Outcomes

More information

IOM Workshop: Achieving Value in Cancer Care: ASCO s Top 5 and Beyond Lowell E. Schnipper, M.D.

IOM Workshop: Achieving Value in Cancer Care: ASCO s Top 5 and Beyond Lowell E. Schnipper, M.D. IOM Workshop: Achieving Value in Cancer Care: ASCO s Top 5 and Beyond Lowell E. Schnipper, M.D. Expenditures Cancer Care: 2010 Initial dx, continuing care, last phase Costs of Cancer Care: breast, colorectal,

More information

PILOT STUDY PROPOSAL FOR EARLY DISCHARGE OF LOW-RISK NEUTROPENIC PATIENTS

PILOT STUDY PROPOSAL FOR EARLY DISCHARGE OF LOW-RISK NEUTROPENIC PATIENTS PILOT STUDY PROPOSAL FOR EARLY DISCHARGE OF LOW-RISK NEUTROPENIC PATIENTS RATIONALE: It is increasingly being recognised that not all neutropenic patients have the same risk of complications during episodes

More information

ILNA Points REFERENCE GUIDE

ILNA Points REFERENCE GUIDE Learn and Earn With ONS Nursing Education REFERENCE GUIDE Resources for AOCNP and AOCNS Renewal About ILNA The Individual Learning Needs Assessment (ILNA) method is the certification renewal process launched

More information

PAEDIATRIC FEBRILE NEUTROPENIA CARE PATHWAY

PAEDIATRIC FEBRILE NEUTROPENIA CARE PATHWAY PAEDIATRIC FEBRILE NEUTROPENIA CARE PATHWAY Purpose: This document is intended as a guide to the investigation and management of children presenting in Salisbury District Hospital with suspected neutropenic

More information

FEBRILE NEUTROPENIA CURRENT GUIDELINES FOR CHILDREN Alia Zaidi, MD. St. Jude International Outreach Program

FEBRILE NEUTROPENIA CURRENT GUIDELINES FOR CHILDREN Alia Zaidi, MD. St. Jude International Outreach Program SIOP PODC Supportive Care Education (ICON 2016) Presentation Date: 23 rd January 2016 Recording Link at www.cure4kids.org: https://www.cure4kids.org/ums/home/conference_rooms/enter.php?room=p25oti35nt7

More information

8/26/17 ONCOLOGY NURSING: WHAT IS ALL THE BUZZ AROUND NAVIGATION, SURVIVORSHIP AND DISTRESS SCREENING IN ONCOLOGY? WELCOME AND DISCLOSURES OBJECTIVES:

8/26/17 ONCOLOGY NURSING: WHAT IS ALL THE BUZZ AROUND NAVIGATION, SURVIVORSHIP AND DISTRESS SCREENING IN ONCOLOGY? WELCOME AND DISCLOSURES OBJECTIVES: ONCOLOGY NURSING: WHAT IS ALL THE BUZZ AROUND NAVIGATION, SURVIVORSHIP AND DISTRESS SCREENING IN ONCOLOGY? 2nd Annual Ellis Fischel Cancer Symposium: Holistic Approach to Cancer Care August 25-26, 2017

More information

Palliative Care for the Hematology Patient

Palliative Care for the Hematology Patient Palliative Care for the Hematology Patient Thomas W. LeBlanc, MD, MA, MHS, FAAHPM Associate Professor of Medicine Division of Hematologic Malignancies Director, Cancer Patient Experience Research Program

More information

Palliative Care in the Continuum of Oncologic Management

Palliative Care in the Continuum of Oncologic Management Palliative Care in the Continuum of Oncologic Management PC in the Routine Continuum of Cancer Care Michael W. Rabow, MD Director, Symptom Management Service Helen Diller Family Comprehensive Cancer Center

More information

The University of Jordan Faculty: Pharmacy Department: Biopharmaceutics and Clinical Pharmacy

The University of Jordan Faculty: Pharmacy Department: Biopharmaceutics and Clinical Pharmacy The University of Jordan Faculty: Pharmacy Department: Biopharmaceutics and Clinical Pharmacy Program: Pharm.D Academic Year/ Semester 2013-2014 Internal medicine clerkship-oncology supportive care (123601)

More information

QOPI and the Rapid Learning Oncology Care System. Copyright 2011 American Society of Clinical Oncology. All rights reserved 1

QOPI and the Rapid Learning Oncology Care System. Copyright 2011 American Society of Clinical Oncology. All rights reserved 1 QOPI and the Rapid Learning Oncology Care System Copyright 2011 American Society of Clinical Oncology. All rights reserved 1 Program Description Quality improvement program for outpatient hematologyoncology

More information

Health Interventions in Ambulatory Cancer Care Centres DRAFT. Objectives. Methods

Health Interventions in Ambulatory Cancer Care Centres DRAFT. Objectives. Methods ENVIRONMENTAL SCAN Health Interventions in Ambulatory Cancer Care Centres Context Cancer, a complex, chronic condition, will affect an estimated two in five Canadians in their lifetime. 1 Cancer requires

More information

Pediatric Trials 23/04/2018. Disclosures. Nausea and Vomiting Control in Adults and Children: Mind the Gap! Learning Objectives

Pediatric Trials 23/04/2018. Disclosures. Nausea and Vomiting Control in Adults and Children: Mind the Gap! Learning Objectives Nausea and Vomiting Control in Adults and Children: Mind the Gap! Disclosures No relevant conflicts of interest Lee Dupuis, RPh, PhD May 5, 2018 2 Learning Objectives At the end of this presentation, attendees

More information

Cancer Survivorship NEURO-ONCOLOGY PATIENT SURVIVORSHIP PLAN. Resources and Tools for the Multidisciplinary Team

Cancer Survivorship NEURO-ONCOLOGY PATIENT SURVIVORSHIP PLAN. Resources and Tools for the Multidisciplinary Team NEURO-ONCOLOGY PATIENT SURVIVORSHIP PLAN Cancer Survivorship Resources and Tools for the Multidisciplinary Team Your survivorship care plan is a summary of your tumor treatments and recommendations for

More information

Cancer in adolescents and Young Adults

Cancer in adolescents and Young Adults 17 th ESO-ESMO Masterclass in Clinical Oncology 24-29 March 2018, Cancer in adolescents and Young Adults Laurence Brugières Gustave Roussy Cancer Center Villejuif, France Cancer in TYA A rare disease in

More information

Guideline Update on Antiemetics

Guideline Update on Antiemetics Guideline Update on Antiemetics Clinical Practice Guideline Special Announcements Please check www.asco.org/guidelines/antiemetics for current FDA alert(s) and safety announcement(s) on antiemetics 2 Introduction

More information

Quality and Fiscal Metrics: What Proves Success?

Quality and Fiscal Metrics: What Proves Success? Quality and Fiscal Metrics: What Proves Success? 1 Quality and Fiscal Metrics: What Proves Success? Kathleen Kerr Kerr Healthcare Analytics Creating the Future of Palliative Care NHPCO Virtual Event February

More information

Inpatient Hospice Palliative Care Directory Facility Update Form

Inpatient Hospice Palliative Care Directory Facility Update Form Inpatient Hospice Palliative Care Directory Facility Update Form Please complete the following form to add a new facility or update your facility details. Complete the form in its entirety. Save and send

More information

Referral guide for acute oncology emergencies

Referral guide for acute oncology emergencies Referral guide for acute oncology emergencies 1 st Edition v 1.0 London Cancer March 2013 To be used in conjunction with London Cancer clinical guidelines for acute oncology emergencies; A Guide to Acute

More information

Need considerable resources material and human.

Need considerable resources material and human. TRAN VAN BINH INTRODUCTION Hematopoietic Stem cell transplantation: the best way to manage Malignancies and non Malignant blood disorders. Need considerable resources material and human. In developping

More information

Antimicrobial Management of Febrile Neutropenic Sepsis

Antimicrobial Management of Febrile Neutropenic Sepsis Antimicrobial Management of Febrile Neutropenic Sepsis Written by: Dr J Joseph, Consultant Haematologist Dr K Gajee, Consultant Microbiologist Amended by: Larissa Claybourn, Antimicrobial Pharmacist Date:

More information

Study No: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study No: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

An Evidence Practice Gap in Antiemetic Prescription with Chemotherapy

An Evidence Practice Gap in Antiemetic Prescription with Chemotherapy 2014 An Evidence Practice Gap in Antiemetic Prescription with Chemotherapy Chepsy C Philip 1*, Biju George 1 1 Department of Clinical Haematology, CMC Vellore, Tamil Nadu, India. ARTICLE INFO Article type:

More information

ONCOLOGY MEDICAL HOME ACCREDITATION

ONCOLOGY MEDICAL HOME ACCREDITATION 2015 Community Oncology Alliance 1 ONCOLOGY MEDICAL HOME ACCREDITATION Panel Moderator: Bo Gamble Director of Strategic Practice Initiatives, Community Oncology Alliance 1 ONCOLOGY MEDICAL HOME ACCREDITATION

More information

DEPARTMENT OF MEDICAL ONCOLOGY

DEPARTMENT OF MEDICAL ONCOLOGY DEPARTMENT OF MEDICAL ONCOLOGY DEPARTMENT OF MEDICAL ONCOLOGY About Narayana Health City One of the leading private healthcare service providers in India, operating a chain of multispecialty, tertiary

More information

Healthcare-associated infection (HCAI) in patients with cancer: Identify the risks and implement preventive measures

Healthcare-associated infection (HCAI) in patients with cancer: Identify the risks and implement preventive measures Employee Handbook of the Royal College of Physicians of Ireland Policy Group on Healthcare-Associated Infection Healthcare-associated infection (HCAI) in patients with cancer: Identify the risks and implement

More information

Treatment of febrile neutropenia in patients with neoplasia

Treatment of febrile neutropenia in patients with neoplasia Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece

More information

Quick facts about gallbladder cancer

Quick facts about gallbladder cancer Quick facts about gallbladder cancer What is the gallbladder? Princess Margaret The gallbladder is a small, pear-shaped organ located under right side of the liver. The gallbladder concentrates and stores

More information

5/3/2016 SEXUALITY: KNOWLEDGE OPENS THE DOOR OBJECTIVES DEFINITIONS CONT. DEFINITIONS

5/3/2016 SEXUALITY: KNOWLEDGE OPENS THE DOOR OBJECTIVES DEFINITIONS CONT. DEFINITIONS SEXUALITY: KNOWLEDGE OPENS THE DOOR TO COMMUNICATION JILL LIBBESMEIER BSN, RN, OCN OBJECTIVES Understand the differences between sexuality, intimacy, sexual health, and sexual dysfunction Identify how

More information

Palliative Care in Adolescents and Young Adults Needs, Obstacles and Opportunities

Palliative Care in Adolescents and Young Adults Needs, Obstacles and Opportunities Palliative Care in Adolescents and Young Adults Needs, Obstacles and Opportunities Justin N Baker, MD, FAAP, FAAHPM Chief, Division of Quality of Life and Palliative Care Attending Physician, Quality of

More information

Quick Facts about Ampullary Cancer

Quick Facts about Ampullary Cancer Quick Facts about Ampullary Cancer What is the Ampulla of Vater? Princess Margaret The liver, gallbladder and pancreas produce important fluids to help you digest food. These fluids are carried through

More information

13/12/26. Febrile Neutropenia (FN) Febrile Neutropenia in 523 Dogs with Various Malignant Tumors. Methods. Our study objective.

13/12/26. Febrile Neutropenia (FN) Febrile Neutropenia in 523 Dogs with Various Malignant Tumors. Methods. Our study objective. The 3 rd Asian Meetings Animal Medicine Specialties 2013 Febrile Neutropenia (FN) Febrile Neutropenia in 523 Dogs with Various Malignant Tumors Fukiko Oshima 1), Tetsuya Kobayashi 1), Eri Fukazawa 1) Yuko

More information

NEWS FROM. Roswell Park s LEUKEMIA SERVICE

NEWS FROM. Roswell Park s LEUKEMIA SERVICE NEWS FROM Roswell Park s LEUKEMIA SERVICE MEET THE LEUKEMIA TEAM The Leukemia Service at Roswell Park Cancer Institute (RPCI) is dedicated to quality patient care, innovative research, and the development

More information

THE ROLE OF PALLIATIVE CARE IN TREATMENT OF PATIENTS WITH CHRONIC, INFECTIOUS DISEASE

THE ROLE OF PALLIATIVE CARE IN TREATMENT OF PATIENTS WITH CHRONIC, INFECTIOUS DISEASE THE ROLE OF PALLIATIVE CARE IN TREATMENT OF PATIENTS WITH CHRONIC, INFECTIOUS DISEASE JESSICA MCFARLIN MD ASSISTANT PROFESSOR OF NEUROLOGY DIVISION CHIEF, PALLIATIVE AND SUPPORTIVE CARE I HAVE NO COI OR

More information

A Care Pathway exists for the management of neutropenic fever. Copies of the care pathway document are available in EAU, A&E, Deanesly and CHU.

A Care Pathway exists for the management of neutropenic fever. Copies of the care pathway document are available in EAU, A&E, Deanesly and CHU. Subject: Neutropenic Fever Guideline for Junior Doctors Date of Implementation: January 2010 Date of Review: January 2012 Director Responsible for Implementation and Review: Policy location: Consultant

More information

CARE PATHWAY FOR CHILDREN AND YOUNG PERSONS WITH FEBRILE NEUTROPENIA, NEUTROPENIC SEPSIS OR SUSPECTED CENTRAL VENOUS LINE INFECTIONS

CARE PATHWAY FOR CHILDREN AND YOUNG PERSONS WITH FEBRILE NEUTROPENIA, NEUTROPENIC SEPSIS OR SUSPECTED CENTRAL VENOUS LINE INFECTIONS CARE PATHWAY FOR CHILDREN AND YOUNG PERSONS WITH FEBRILE NEUTROPENIA, NEUTROPENIC SEPSIS OR SUSPECTED CENTRAL VENOUS LINE INFECTIONS This Care Pathway has been developed by a multidisciplinary team. It

More information

Updates in Chemotherapy-Induced Nausea and Vomiting (CINV) 2017

Updates in Chemotherapy-Induced Nausea and Vomiting (CINV) 2017 Updates in Chemotherapy-Induced Nausea and Vomiting (CINV) 2017 MELISSA C. MACKEY, PHARMD, BCPS, BCOP ONCOLOGY CLINICAL PHARMACIST DUKE UNIVERSITY HOSPITAL AUGUST 5, 2017 Objectives Review risk factors

More information

1. Adequate diet and iron intake to prevent iron deficiency 2. Signs and symptoms of malignant disease

1. Adequate diet and iron intake to prevent iron deficiency 2. Signs and symptoms of malignant disease Hematology/Oncology Description: The pediatric hematology-oncology division sees a wide spectrum of pediatric disease including but not limited to leukemia, hemophilia, solid tumors, ITP, and other blood

More information

Learn and Earn With ONS Nursing Education. ILNA Points REFERENCE GUIDE. Resources for CBCN Renewal.

Learn and Earn With ONS Nursing Education. ILNA Points REFERENCE GUIDE. Resources for CBCN Renewal. Learn and Earn With ONS Nursing Education REFERENCE GUIDE Resources for CBCN Renewal www.ons.org About The Individual Learning Needs Assessment () method is the certification renewal process that launched

More information

Reference No: SG 23/13

Reference No: SG 23/13 Title: Author(s) Ownership: Approval by: Guidelines for the use of granulocyte colony stimulating factor (GSCF) in adult oncology & malignant haematology patients Paula Scullin, Consultant Medical Oncologist,

More information

Hematology/Oncology/BMT

Hematology/Oncology/BMT The University of Arizona Pediatric Residency Program Primary Goals for Rotation Hematology/Oncology/BMT 1. GOAL: Understand the role of the pediatrician in preventing hematologic or oncologic conditions,

More information

Why Patients Experience Nausea and Vomiting and What to Do About It

Why Patients Experience Nausea and Vomiting and What to Do About It Why Patients Experience Nausea and Vomiting and What to Do About It Rebecca Clark-Snow, RN, BSN, OCN The University of Kansas Cancer Center Westwood, Kansas Multiple Roles for Supportive Care in Cancer

More information

Matti Aapro MD Genolier, Switzerland Member of the ESMO Supportive Care Faculty

Matti Aapro MD Genolier, Switzerland Member of the ESMO Supportive Care Faculty «Spotlight» Case-based management of supportive and palliative care Matti Aapro MD Genolier, Switzerland Member of the ESMO Supportive Care Faculty Past-President of MASCC ( Multinational Association for

More information